EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation.
Saved in:
| Title: | EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation. |
|---|---|
| Authors: | Diefenbach K; Bayer HealthCare Pharmaceuticals, Berlin, Germany., Trummer D, Ebert F, Lissy M, Koch M, Rohde B, Blode H |
| Source: | International journal of women's health [Int J Womens Health] 2013 Apr 11; Vol. 5, pp. 149-63. Date of Electronic Publication: 2013 Apr 11 (Print Publication: 2013). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101531698 Publication Model: Electronic-Print Cited Medium: Print ISSN: 1179-1411 (Print) Linking ISSN: 11791411 NLM ISO Abbreviation: Int J Womens Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
